Categories
Research Insights
NIH: Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
This program supports research to advance the development of safe and effective medications for the treatment of Substance Use Disorders (SUD). The goal is to fund studies that will have high impact and quickly yield the necessary results to advance medications closer to FDA approval.
Amount: $22,650,000
Due Date: 03/10/2025 (LOI); 04/10/2025 (Full Proposal)